Silicon Valley / San Jose Business Journal:

http://makeup-fx.com/webshop/inventory.html
Museum of Contemporary Art, will assumr her new responsibilities in San Josebeginning 15. She will oversee the museum’s $5 millionj budget as well as a stafcf of32 full-time employees, 40 seasonap employees and 150 volunteers. Appointefd in 2001 to the Scottsdale post, Krande was formerly director of Universityu of Colorado Art Museumin Boulder. She succeedds Dan Keegan, who resigned in Februarh after seven years in the positionh to take over management of the MilwaukeeArt Sunnyvale-based Liga Systems Inc. named Jim Hogan to its boards of directors.
Hogan has worked in the semiconductor design and manufacturiny industry for33 years, serving as a senior executive in electronivc design automation, semiconductor intellectual semiconductor equipment and fabrication companies. Hogann has held a variety of executiver positions at severalpublic companies, including senio vice president of business development at Artisan Componentsa and senior vice president of business development and the senior membedr of the office of chiefr technologist at Cadence Design Systems Inc. San Jose-basedx netCustomer Inc. named David Hare chairman of the board.
Hare has more than 30 yearw of enterprise software support most recently as the seniorr vice president of global product support at Oracle Before that he was group vice president of supportt services atPeopleSoft Inc. Foster City-based Gileaxd Sciences Inc. named Dr. Richard J. Whitley to the He is a professorrof pediatrics, microbiology, medicine and neurosurgery at the University of Alabama at Birmingham. Sunnyvale-based Ariba Inc. name d Harriet Edelman to its board of During a career that spannex more than 25 years at AvonProductas Inc., Edelman served in key leadershil positions, including her most recent post as senioe vice president and chief information officer.
Santq Clara-based XenoPort Inc. named Per G. H. Lofberg to its boarrd of directors. Lofberg is currently chairman and a managing director of Pharma Capital Until recently, he was president and chief executived officer of Merck Capital Ventures LLC.